SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 4)
Reinsurance Group of America, Incorporated
--------------------------------------------------------
(Name of Issuer)
Common Stock, Par Value $.01 Per Share
--------------------------------------------------------
(Title of Class of Securities)
759351109
--------------------------------------------------------
(CUSIP Number)
Gwenn L. Carr
MetLife, Inc.
One Madison Avenue
New York, New York 10010
(212)578-2211
--------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
January 30, 2002
--------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g),
check the following box [ ].
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
SCHEDULE 13D CUSIP No. 759351109
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
MetLife, Inc.
13-4075851
-------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
-------------------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------------------
4 SOURCE OF FUNDS
WC
-------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e) [ ]
-------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY 222,800*
OWNED BY ----------------------------------------------------------
EACH 8 SHARED VOTING POWER
REPORTING
PERSON 28,915,939*
WITH ----------------------------------------------------------
9 SOLE DISPOSITIVE POWER
222,800*
----------------------------------------------------------
10 SHARED DISPOSITIVE POWER
28,915,939*
-------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
29,138,739*
-------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
[ ]
-------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
58.9%*
-------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
HC
-------------------------------------------------------------------------------
* See Item 5 below. Unless otherwise indicated, all information relating to
beneficial ownership of the Shares by the Reporting Persons is as of
February 15, 2002.
Page 2 of 26
SCHEDULE 13D CUSIP No. 759351109
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Metropolitan Life Insurance Company
13-5581829
-------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
-------------------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------------------
4 SOURCE OF FUNDS
Not Applicable
-------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [ ]
-------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
New York
-------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY None*
OWNED BY ----------------------------------------------------------
EACH 8 SHARED VOTING POWER
REPORTING
PERSON 28,915,939*
WITH ----------------------------------------------------------
9 SOLE DISPOSITIVE POWER
None*
----------------------------------------------------------
10 SHARED DISPOSITIVE POWER
28,915,939*
-------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
28,915,939*
-------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ]
-------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
58.5%*
-------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IC
-------------------------------------------------------------------------------
* See Item 5 below. Unless otherwise indicated, all information relating to
beneficial ownership of the Shares by the Reporting Persons is as of
February 15, 2002.
Page 3 of 26
SCHEDULE 13D CUSIP No. 759351109
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
GenAmerica Financial Corporation
43-1779470
-------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
-------------------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------------------
4 SOURCE OF FUNDS
Not Applicable
-------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [ ]
-------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Missouri
-------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY None*
OWNED BY ----------------------------------------------------------
EACH 8 SHARED VOTING POWER
REPORTING
PERSON 24,131,250*
WITH ----------------------------------------------------------
9 SOLE DISPOSITIVE POWER
None*
----------------------------------------------------------
10 SHARED DISPOSITIVE POWER
24,131,250*
-------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
24,131,250*
-------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
[ ]
-------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
48.8%*
-------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
HC, CO
-------------------------------------------------------------------------------
* See Item 5 below. Unless otherwise indicated, all information relating to
beneficial ownership of the Shares by the Reporting Persons is as of
February 15, 2002.
Page 4 of 26
SCHEDULE 13D CUSIP No. 759351109
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
General American Life Insurance Company
43-0285930
-------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
-------------------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------------------
4 SOURCE OF FUNDS
Not Applicable
-------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [ ]
-------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Missouri
-------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY None*
OWNED BY ----------------------------------------------------------
EACH 8 SHARED VOTING POWER
REPORTING
PERSON 24,131,250*
WITH ----------------------------------------------------------
9 SOLE DISPOSITIVE POWER
None*
----------------------------------------------------------
10 SHARED DISPOSITIVE POWER
24,131,250*
-------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
24,131,250*
-------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
[ ]
-------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
48.8%*
-------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IC
-------------------------------------------------------------------------------
* See Item 5 below. Unless otherwise indicated, all information relating to
beneficial ownership of the Shares by the Reporting Persons is as of
February 15, 2002.
Page 5 of 26
SCHEDULE 13D CUSIP No. 759351109
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Equity Intermediary Company
43-1727895
-------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
-------------------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------------------
4 SOURCE OF FUNDS
Not Applicable
-------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [ ]
-------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Missouri
-------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY None*
OWNED BY ----------------------------------------------------------
EACH 8 SHARED VOTING POWER
REPORTING
PERSON 24,131,250*
WITH ----------------------------------------------------------
9 SOLE DISPOSITIVE POWER
None*
----------------------------------------------------------
10 SHARED DISPOSITIVE POWER
24,131,250*
-------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
24,131,250*
-------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
[ ]
-------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
48.8%*
-------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
HC, CO
-------------------------------------------------------------------------------
* See Item 5 below. Unless otherwise indicated, all information relating to
beneficial ownership of the Shares by the Reporting Persons is as of
February 15, 2002.
Page 6 of 26
SCHEDULE 13D CUSIP No. 759351109
This Statement relates to the common stock, par value $.01 per share (the
"Shares"), of Reinsurance Group of America, Incorporated, a Missouri corporation
("RGA"). This Statement amends the Schedule 13D Statement of MetLife, Inc. in
respect of RGA by amending and restating Items 2,5 and 7 in their entirety, as
follows:
Item 2. Identity and Background.
(a) through (c) and (f). This Statement is filed on behalf of (i)
MetLife, Inc. ("MLINC"), (ii) Metropolitan Life Insurance Company ("MetLife"), a
wholly owned subsidiary of MLINC, (iii) GenAmerica Financial Corporation, a
wholly owned subsidiary of MetLife ("GenAmerica"), (iv) General American Life
Insurance Company, a wholly owned subsidiary of GenAmerica ("GenAm Life"), and
(v) Equity Intermediary Company, a wholly owned subsidiary of GenAm Life ("EIM")
(MLINC, MetLife, GenAmerica, GenAm Life and EIM are referred to herein
collectively as the "Filing Parties"). MLINC, a Delaware corporation with its
principal office and business at One Madison Avenue, New York, NY, 10010-3690,
is not controlled by any person or persons and is a holding company which owns
all of the issued and outstanding shares of common stock of MetLife. MetLife, a
New York life insurance company, has its principal office and business at One
Madison Avenue, New York, New York 10010-3690. GenAmerica and EIM are holding
companies and GenAm Life is an insurance company. GenAmerica, GenAm Life and EIM
are each Missouri corporations with the address of their principal offices and
businesses at 700 Market Street, St. Louis, Missouri 63101.
Set forth on Exhibit A to this Statement, and incorporated herein by
reference, is the name, residence or business address, present principal
occupation or employment (and the name, principal business and address of any
corporation or other organization in which such employment is conducted) and
citizenship of each director and executive officer of the Filing Parties.
(d) During the last five years, none of the Filing Parties nor, to the
best knowledge of the Filing Parties, any of their respective executive officers
or directors has been convicted in a criminal proceeding (excluding traffic
violations or similar misdemeanors).
(e) During the last five years, none of the Filing Parties nor, to the
best knowledge of the Filing Parties, any of their respective executive officers
or directors has been a party to a civil proceeding of a judicial or
administrative body of competent jurisdiction and as a result of such proceeding
was or is subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to, federal or
state securities laws or finding any violation with respect to such laws.
Item 5. Interest in Securities of the Issuer.
(a) and (b). As of February 15, 2002, MLINC and MetLife beneficially
owned 29,138,739 Shares, or approximately 58.9 percent of the outstanding
Shares. Of such Shares, MLINC has sole voting and dispositive power with respect
to 222,800 Shares, MLINC and MetLife share voting and dispositive power with
each other with respect to 4,784,689 Shares and share voting and dispositive
power with GenAmerica, GenAm Life and EIM with respect to 24,131,250 Shares. As
of February 15, 2002, GenAmerica, GenAm Life and EIM beneficially owned
24,131,250 Shares, or approximately 48.8 percent of the outstanding Shares. With
respect to such Shares, GenAmerica, GenAm Life and EIM share voting and
dispositive power with MLINC, MetLife and each other. See also Item 2 above.
The information in the following paragraphs is to the best knowledge of
the Filing Parties.
Page 7 of 26
SCHEDULE 13D CUSIP No. 759351109
As of February 2, 2002, William E. Cornelius, a director of GenAmerica
and GenAm Life, beneficially owned 1,113 Shares and had sole voting and
dispositive power with respect to such Shares.
As of February 19, 2002, Arnold W. Donald, a director of GenAmerica and
GenAm Life, may be deemed to be the beneficial owner of 105 Shares held by Hazel
Donald, as trustee of a trust. Mr. Donald did not have voting or dispositive
power with respect to such Shares.
As of February 1, 2002, Richard D. Evans, Senior Vice President -
Sales, National Accounts and Special Programs of GenAm Life, beneficially owned
100 Shares and had sole voting and dispositive power with respect to such
Shares.
As of February 14, 2002, James W. Koeger, Vice President of MetLife and
a director of EIM, beneficially owned 700 Shares and had sole voting and
dispositive power with respect to such Shares.
As of February 5, 2002, Richard A. Liddy, Chairman of GenAmerica and
GenAm Life, may be deemed to have been the beneficial owner of 132,200 Shares,
(i) 112,500 Shares which were owned directly by Mr. Liddy, and (ii) 19,700
Shares which were owned by Joanne S. Liddy, his spouse. Mr. Liddy had sole
voting and dispositive power with respect to the shares owned directly by him,
and shared voting and dispositive power with respect to such Shares owned by his
spouse. Mr. Liddy disclaimed beneficial ownership of the aforementioned Shares
owned by his spouse.
As of February 4, 2002, Matthew P. McCauley, a director of EIM and
Vice-President, General Counsel and Secretary of GenAmerica and GenAm Life,
beneficially owned 1,000 Shares which were jointly owned with Brigid K.
McCauley, and shared voting and dispositive power with respect to such Shares
with her.
As of February 1, 2002, Stewart G. Nagler, Vice Chairman of the Board
and Chief Financial Officer of MLINC and MetLife, a director of GenAmerica and
GenAm Life and Chairman of the Board of RGA, beneficially owned 1,000 Shares and
had sole voting and dispositive power with respect to such Shares.
As of February 4, 2002, John E. Petersen, Senior Vice President of
GenAm Life, beneficially owned 150 Shares and had sole voting and dispositive
power with respect to such Shares.
As of February 14, 2002, Craig D. Schnuck, a director of GenAmerica and
GenAm Life, beneficially owned 2,000 Shares and had sole voting and dispositive
power with respect to such Shares.
As of February 6, 2002, William P. Stiritz, a director of GenAmerica
and GenAm Life, beneficially owned 9,933 Shares and had sole voting and
dispositive power with respect to such Shares.
As of February 4, 2002, Andrew C. Taylor, a director of GenAmerica and
GenAm Life, beneficially owned 26,000 Shares and shared voting and dispositive
power with respect to such Shares with Barbara B. Taylor.
As of February 5, 2002, Robert L. Virgil, a director of GenAmerica and
GenAm Life, beneficially owned 225 Shares which were owned by Geraldine J.
Virgil, his spouse, and shared voting and dispositive power with respect to such
Shares with her.
Page 8 of 26
SCHEDULE 13D CUSIP No. 759351109
As of February 2, 2002, Virginia V. Weldon, M.D. a director of
GenAmerica and GenAm Life, beneficially owned 450 Shares as trustee of a trust,
and had sole voting and dispositive power with respect to such Shares.
As of February 4, 2002, Bernard H. Wolzenski, Executive Vice-President
- Individual, of GenAmerica and GenAm Life, may be deemed to be the beneficial
owner of 2,725 Shares held by Jeanne A. Wolzenski, as trustee of a trust. Mr.
Wolzenski did not have voting or dispositive power with respect to such Shares.
As of February 6, 2002, A. Greig Woodring, Executive Vice-President -
Reinsurance of GenAmerica and GenAm Life and President and Chief Executive
Officer of RGA, may be deemed to have been the beneficial owner of 323,557
Shares and had sole voting and dispositive power with respect to such Shares.
Some of the Shares described in the above paragraphs may be in the form
of stock options exercisable within 60 days or restricted stock. None of the
Share ownership described in the above paragraphs represents beneficial
ownership by any individual of more than 1% of the outstanding Shares.
The percentage amounts set forth in this Item 5 are based upon the
number of Shares issued and outstanding as of October 31, 2001, as described in
RGA's Quarterly Report on Form 10-Q for the quarterly period ended September 30,
2001.
(c) In the 60 days prior to the date of filing of this Statement, none
of the Filing Parties nor, to the best knowledge of the Filing Parties, any of
their respective directors and executive officers has effected any transactions
in the Shares, except as disclosed in this Statement, and except the following:
Susan Stiritz sold 17,500 Shares on January 9, 2002 at $32.00 per Share.
Stewart G. Nagler purchased 1,000 Shares on February 1, 2002 at $29.00 per
Share.
Between January 30, 2002 and February 15, 2002, MLINC purchased a total of
222,800 Shares. Details regarding these purchases are set forth in Exhibit C
hereto.
(d) No other person is known by the Filing Parties to have the right to
receive or the power to direct the receipt of dividends from, and the proceeds
from the sale of, the Shares.
(e) Not applicable.
Item 7. Materials to be Filed as Exhibits.
Exhibit A -- Information relating to the Executive Officers and Directors of
the Filing Parties
Exhibit B -- Agreement Required for Joint Filing under Rule 13d-1(k)(1)
Exhibit C -- Purchases of Shares by MetLife, Inc.
Page 9 of 26
SCHEDULE 13D CUSIP No. 759351109
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated: February 20, 2002
METLIFE, INC.
By: /s/ Gwenn L. Carr
-----------------
Name: Gwenn L. Carr
Title: Vice-President and Secretary
METROPOLITAN LIFE INSURANCE COMPANY
By: /s/ Gwenn L. Carr
-----------------
Name: Gwenn L. Carr
Title: Vice-President and Secretary
GENAMERICA FINANCIAL CORPORATION
By: /s/ Matthew P. McCauley
-----------------------
Name: Matthew P. McCauley
Title: Vice-President, General
Counsel and Secretary
GENERAL AMERICAN LIFE INSURANCE COMPANY
By: /s/ Matthew P. McCauley
------------------------
Name: Matthew P. McCauley
Title: Vice-President, General
Counsel and Secretary
EQUITY INTERMEDIARY COMPANY
By: /s/ Matthew P. McCauley
------------------------
Name: Matthew P. McCauley
Title: Director, Vice-President,
General Counsel and Secretary
Page 10 of 26
SCHEDULE 13D CUSIP No. 759351109
EXHIBIT A
DIRECTORS AND EXECUTIVE OFFICERS OF THE FILING PARTIES
Set forth below is the name and present principal occupation or employment of
each director and executive officer of MLINC and MetLife. MLINC is a holding
company and MetLife is an insurance company. The principal business address of
MLINC and MetLife is One Madison Avenue, New York, NY 10010-3690. Each person
listed below is a citizen of the United States.
DIRECTORS
Name And Business Address Principal Occupation or Employment
------------------------- ----------------------------------
Curtis H. Barnette Of Counsel, Skadden, Arps, Slate,
Skadden, Arps, Slate, Meagher & Flom LLP (law firm)
Meagher & Flom LLP
1440 New York Avenue, N.W.
Washington, DC 20005-2111
Robert H. Benmosche Chairman of the Board, President
and Chief Executive Officer, MLINC and MetLife
Gerald Clark Vice-Chairman of the Board and
Chief Investment Officer, MLINC and MetLife
Joan Ganz Cooney* Chairman, Executive Committee
Children's Television Workshop Children's Television Workshop
One Lincoln Plaza (broadcasting)
New York, New York 10023
John C. Danforth Partner, Bryan Cave LLP (law firm)
Bryan Cave LLP
211 N. Broadway, Suite 3600
St. Louis, MO 63102-2750
Burton A. Dole, Jr. Retired Chairman, President and
P.O. Box 208 Chief Executive Officer, Puritan
Pauma Valley, Bennett, Incorporated (medical device
California 92061 manufacturing)
James R. Houghton Non-Executive Chairman of the Board,
Corning Incorporated Corning Incorporated (telecommunications
80 East Market Street technology)
2nd Floor,
Corning, New York 14830
Harry P. Kamen Retired Chairman of the Board and
Metropolitan Life Insurance Co. Chief Executive Officer, MetLife
200 Park Avenue, Suite 5700
New York, New York 10166
Page 11 of 26
SCHEDULE 13D CUSIP No. 759351109
Helene L. Kaplan Of Counsel, Skadden, Arps, Slate,
Skadden, Arps, Slate, Meagher and Flom LLP (law firm)
Meagher & Flom LLP
Four Times Square
New York, New York 10036
Catherine R. Kinney Co-Chief Operating Officer, President
New York Stock Exchange, Inc. and Executive Vice Chairman, New York
20 Broad Street Stock Exchange, Inc.
New York, New York 10005
Charles M. Leighton Retired Chairman and Chief Executive
P. O. Box 247 Officer, CML Group, Inc. (exercise
Bolton, MA 01740 and leisure products)
Allen E. Murray* Retired Chairman of the Board and
Mobil Corporation Chief Executive Officer, Mobil
375 Park Avenue, Suite 2901 Corporation (petroleum refining)
New York, New York 10152
Stewart G. Nagler Vice-Chairman of the Board and Chief
Financial Officer, MLINC and MetLife;
Chairman of the Board, RGA
John J. Phelan, Jr. Senior Advisor, Boston Consulting Group
P.O. Box 312
Mill Neck, New York 11765
Hugh B. Price President and Chief Executive
National Urban League, Inc. Officer, National Urban League, Inc.
500 East 62nd Street
New York, New York 10005
William G. Steere, Jr. Retired Chairman of the Board and Chief
Pfizer Inc. Executive Officer, Pfizer Inc.
235 East 42nd Street
New York, New York 10017
* Joan Ganz Cooney and Allen Murray will retire from the Boards of MLINC and
MetLife effective March 31, 2002.
Executive Officers
(Who are not Directors)
Name Principal Occupation or Employment
---- ----------------------------------
Gary A. Beller Senior Executive Vice-President and
General Counsel, MLINC and MetLife
James M. Benson President, Individual Business, MLINC and
MetLife; Chairman, Chief Executive Officer
and President, New England Life
Insurance Company
C. Robert Henrikson President, Institutional Business, MLINC and
MetLife
Page 12 of 26
SCHEDULE 13D CUSIP No. 759351109
Catherine A. Rein Senior Executive Vice-President, MLINC and
MetLife; President and Chief Executive
Officer, Metropolitan Property and
Casualty Insurance Company
William J. Toppeta President, International, MLINC and MetLife
Lisa M. Weber Senior Executive Vice-President and Chief
Administrative Officer, MLINC and MetLife
Set forth below is the name and present principal occupation or employment of
each director and executive officer of GenAmerica and GenAm Life. GenAmerica is
a holding company and GenAm Life is an insurance company. The principal business
address of each of GenAmerica and GenAm Life is 700 Market Street, St. Louis,
Missouri 63101. Each person listed below is a citizen of the United States.
DIRECTORS
Name And Business Address Principal Occupation or Employment
------------------------- ----------------------------------
James M. Benson President, Individual Business, MLINC and
Metropolitan Life Insurance Co. MetLife; Chairman, Chief Executive Officer
One Madison Avenue and President, New England Life
New York, New York 10010-3690 Insurance Company
William E. Cornelius Retired Chairman and Chief Executive Officer
#2 Dunlora Lane Union Electric Company (now Ameren
St. Louis, Missouri 63131 Corporation) (electric utility)
John C. Danforth Partner, Bryan Cave LLP (law firm)
Bryan Cave LLP
One Metropolitan Square,
Suite 3600
St. Louis, Missouri 63102
Arnold W. Donald Chairman and Chief Executive Officer,
Merisant Company Merisant Company
1 N. Brentwood Blvd.
Suite 510
St. Louis, MO 63105
Kevin C. Eichner President and Chief Executive Officer,
GenAmerica and GenAm Life
Jerald L. Kent President and Chief Executive Officer,
12412 Powerscourt Dr. Cequel III, LLC
Suite 100
St. Louis, MO 63131
Richard A. Liddy Chairman, Retired President and Chief
Executive Officer, GenAmerica and GenAm Life
Page 13 of 26
SCHEDULE 13D CUSIP No. 759351109
Stewart G. Nagler Vice-Chairman of the Board and Chief
Metropolitan Life Insurance Co. Financial Officer, MLINC and MetLife;
One Madison Avenue Chairman of the Board, RGA
New York, New York 10010-3690
Craig D. Schnuck Chairman and Chief Executive Officer,
Schnuck Markets, Inc. Schnuck Markets, Inc. (retail grocery
11420 Lackland Road stores)
St. Louis, Missouri 63146
William P. Stiritz Chairman, Energizer Holding Company and
Agribrands International, Inc. Ralcorp Holdings Inc.
1401 South Brentwood Blvd.
Suite 650
St. Louis, Missouri 63144
Andrew C. Taylor Chairman and Chief Executive Officer,
Enterprise Rent-A-Car Company Enterprise Rent-A-Car Company (automobile
600 Corporate Park Drive rental and leasing)
St. Louis, Missouri 63105
Robert L. Virgil Management Consultant and Subordinated
Edward Jones & Co. Limited Partner, Edward Jones & Co.
12555 Manchester Road (securities firm)
St. Louis, Missouri 63131
Lisa M. Weber Senior Executive Vice-President and Chief
Metropolitan Life Insurance Co. Administrative Officer, MLINC and MetLife
One Madison Avenue
New York, New York 10010-3690
Virginia V. Weldon Retired Senior Vice-President for Public
242 Carlyle Lake Drive Policy, Monsanto Company (life sciences)
St. Louis, Missouri 63141
Executive Officers of GenAmerica and/or GenAm Life
(Who Are Not Directors)
Name Principal Occupation or Employment
---- ----------------------------------
Richard D. Evans Senior Vice-President - Sales, National
Accounts and Special Programs, GenAm Life
Timothy J. Klopfenstein Vice President and Chief Financial Officer,
Individual Product Division, GenAm Life;
President and Treasurer, EIM
Matthew P. McCauley Vice-President, General Counsel and
Secretary, GenAmerica and GenAm Life
Daniel J. McDonald Senior Vice-President, GenAm Life
Richard J. Miller Executive Vice-President and Chief Marketing
Officer, GenAm Life
Jerome M. Mueller Senior Vice-President - National Marketing,
GenAm Life
Page 14 of 26
SCHEDULE 13D CUSIP No. 759351109
John E. Petersen Senior Vice-President, GenAm Life
William S. Slater Senior Vice-President, GenAm Life
Bernard H. Wolzenski Executive Vice-President - Individual,
GenAmerica and GenAm Life
A. Greig Woodring Executive Vice-President - Reinsurance,
RGA GenAmerica and GenAm Life; President and
1370 Timberlake Parkway Chief Executive Officer, RGA
Chesterfield, MO 63017
Set forth below is the name and present principal occupation or employment of
each director and executive officer of EIM. EIM is a holding company. The
principal business address of EIM is 700 Market Street, St. Louis, Missouri
63101. Each person listed below is a citizen of the United States.
DIRECTORS
Name And Business Address Principal Occupation or Employment
------------------------- ----------------------------------
Timothy J. Klopfenstein Vice President and Chief Financial Officer,
Individual Product Division, GenAm Life;
President and Treasurer, EIM
James W. Koeger Vice President, MetLife; Assistant
Treasurer, GenAmerica, GenAm Life and EIM
Matthew P. McCauley Vice-President, General Counsel and
Secretary, GenAmerica, GenAm Life and EIM
Page 15 of 26
SCHEDULE 13D CUSIP No. 759351109
Exhibit B
Joint Filing Agreement
In accordance with Rule 13d-1(k)(1) of Regulation 13D-G of the Securities
Exchange Act of 1934, the persons or entities below agree to the joint filing on
behalf of each of them of the Statement on Schedule 13D (including any and all
amendments thereto) with respect to the Common Stock of Reinsurance Group of
America, Incorporated, and agree that such statement is, and any amendments
thereto filed by any of them will be, filed on behalf of each of them, and
further agree that this Joint Filing Agreement be included as an Exhibit to such
joint filings.
In evidence thereof the undersigned hereby execute this Agreement this 20th day
of February, 2002.
METLIFE, INC.
By: /s/ Gwenn L. Carr
-----------------
Name: Gwenn L. Carr
Title: Vice-President and Secretary
METROPOLITAN LIFE INSURANCE COMPANY
By: /s/ Gwenn L. Carr
-----------------
Name: Gwenn L. Carr
Title: Vice-President and Secretary
GENAMERICA FINANCIAL CORPORATION
By: /s/ Matthew P. McCauley
-----------------------
Name: Matthew P. McCauley
Title: Vice-President, General
Counsel and Secretary
GENERAL AMERICAN LIFE INSURANCE COMPANY
By: /s/ Matthew P. McCauley
-----------------------
Name: Matthew P. McCauley
Title: Vice-President, General
Counsel and Secretary
EQUITY INTERMEDIARY COMPANY
By: /s/ Matthew P. McCauley
-----------------------
Name: Matthew P. McCauley
Title: Director, Vice-President,
General Counsel and Secretary
Page 16 of 26
SCHEDULE 13D CUSIP No. 759351109
Exhibit C
Purchases of Shares by MetLife, Inc.
January 30, 2002
SHARES
TRADE LOT PURCHASED PRICE
--------- --------- -------
1 600 27.64
2 700 27.66
3 1800 27.7
4 100 27.72
5 400 27.73
6 1800 27.75
7 4000 27.78
8 1400 27.79
9 4000 27.8
10 800 27.82
11 13200 27.85
12 1700 27.88
13 4500 27.89
14 9700 27.9
15 6200 27.91
16 400 27.92
17 100 27.94
18 1100 27.95
19 900 27.96
20 4700 27.98
21 5300 27.99
22 12600 28.00
76,000 27.8924
Page 17 of 26
SCHEDULE 13D CUSIP No. 759351109
January 31, 2002
SHARES
TRADE LOT PURCHASED PRICE
--------- --------- -------
1 1250 27.99
2 750 28
3 250 28.1
4 1350 28.25
5 50 28.26
6 1850 28.3
7 1000 28.33
8 200 28.34
9 200 28.35
10 150 28.39
11 100 28.4
12 250 28.41
13 500 28.45
14 150 28.52
15 850 28.54
16 1100 28.55
17 200 28.62
18 550 28.64
19 500 28.7
20 100 28.71
21 150 28.72
11,500 28.3443
February 1, 2002
SHARES
TRADE LOT PURCHASED PRICE
--------- --------- -------
1 150 28.63
2 400 28.65
3 3850 28.7
4 300 28.71
5 5400 28.75
6 300 28.76
7 150 28.77
8 3450 28.79
9 1000 28.8
10 1350 28.92
11 450 28.93
12 3200 29
20,000 28.8021
Page 18 of 26
SCHEDULE 13D CUSIP No. 759351109
February 4, 2002
SHARES
TRADE LOT PURCHASED PRICE
--------- --------- -------
1 50 28.34
2 300 28.35
3 1650 28.39
4 950 28.4
5 650 28.44
6 100 28.45
7 550 28.46
8 100 28.47
9 350 28.5
10 700 28.55
11 1400 28.56
12 1100 28.57
13 4250 28.59
14 350 28.6
15 1450 28.9
16 50 28.95
14,000 28.5584
Page 19 of 26
SCHEDULE 13D CUSIP No. 759351109
February 5, 2002
SHARES
TRADE LOT PURCHASED PRICE
--------- --------- -------
1 250 27.85
2 250 27.95
3 100 28
4 500 28.03
5 250 28.05
6 150 28.06
7 50 28.09
8 450 28.1
9 1,450 28.11
10 450 28.12
11 100 28.13
12 800 28.15
13 150 28.19
14 1,050 28.21
15 350 28.22
16 450 28.25
17 100 28.28
18 250 28.3
19 200 28.31
20 100 28.33
21 650 28.35
22 50 28.39
23 100 28.4
24 400 28.47
25 900 28.55
9,550 28.2083
Page 20 of 26
SCHEDULE 13D CUSIP No. 759351109
February 6, 2002
SHARES
TRADE LOT PURCHASED PRICE
--------- --------- -------
1 50 28.15
2 450 28.16
3 150 28.17
4 300 28.22
5 700 28.23
6 50 28.25
7 100 28.29
8 900 28.3
9 1300 28.31
10 2500 28.35
11 250 28.36
12 350 28.37
13 250 28.38
14 1200 28.42
15 850 28.43
16 1600 28.44
11,000 28.3463
February 7, 2002
SHARES
TRADE LOT PURCHASED PRICE
--------- --------- -------
1 600 28.05
2 1450 28.1
3 700 28.14
4 50 28.19
5 150 28.2
6 1100 28.21
7 50 28.22
8 50 28.23
9 250 28.24
10 100 28.26
11 750 28.3
12 500 28.39
13 750 28.4
6,500 28.2111
Page 21 of 26
SCHEDULE 13D CUSIP No. 759351109
February 8, 2002
SHARES
TRADE LOT PURCHASED PRICE
--------- --------- -------
1 200 28.45
2 50 28.50
3 50 28.55
4 50 28.60
5 350 28.70
6 100 28.78
7 50 28.79
8 50 28.80
9 50 28.81
10 4,900 28.82
11 750 28.83
12 200 28.84
13 100 28.86
14 100 28.88
15 950 28.89
16 500 28.90
17 400 28.92
18 450 28.93
19 500 28.94
20 150 28.95
21 150 28.96
22 1,100 28.97
23 3,700 28.99
24 1,850 29.00
16,750 28.8965
Page 22 of 26
SCHEDULE 13D CUSIP No. 759351109
February 11, 2002
SHARES
TRADE LOT PURCHASED PRICE
--------- --------- -------
1 150 29.03
2 250 29.10
3 200 29.15
4 650 29.18
5 350 29.20
6 950 29.25
7 250 29.27
8 550 29.28
9 150 29.29
10 100 29.30
11 200 29.34
12 50 29.35
13 200 29.36
14 150 29.37
15 150 29.38
16 1,700 29.39
17 250 29.40
18 200 29.43
19 250 29.45
20 50 29.50
21 300 29.51
22 350 29.52
23 150 29.54
24 550 29.55
25 50 29.60
26 50 29.64
27 1,250 29.65
28 50 29.67
29 50 29.68
30 1,400 29.70
11,000 29.4251
Page 23 of 26
SCHEDULE 13D CUSIP No. 759351109
February 12, 2002
SHARES
TRADE LOT PURCHASED PRICE
--------- --------- -------
1 900 29.20
2 600 29.22
3 1,200 29.30
4 700 29.31
5 250 29.32
6 500 29.33
7 350 29.34
8 50 29.37
9 300 29.38
10 2,000 29.39
11 650 29.40
12 800 29.45
13 300 29.46
14 100 29.48
15 300 29.52
16 50 29.54
17 100 29.55
18 50 29.56
19 300 29.57
20 150 29.58
21 200 29.59
22 950 29.60
23 1,700 29.61
12,500 29.4176
Page 24 of 26
SCHEDULE 13D CUSIP No. 759351109
February 13, 2002
SHARES
TRADE LOT PURCHASED PRICE
--------- --------- -------
1 100 29.07
2 50 29.09
3 250 29.15
4 250 29.20
5 100 29.21
6 850 29.27
7 150 29.28
8 50 29.30
9 1,000 29.40
10 250 29.41
11 550 29.43
12 400 29.47
13 100 29.49
14 700 29.50
15 150 29.51
16 850 29.55
17 650 29.58
18 750 29.59
19 2,300 29.60
20 250 29.75
21 150 29.81
22 300 29.83
23 450 29.84
24 850 29.85
11,500 29.5334
Page 25 of 26
SCHEDULE 13D CUSIP No. 759351109
February 14, 2002
SHARES
TRADE LOT PURCHASED PRICE
--------- --------- -------
1 500 29.50
2 250 29.55
3 2,000 29.59
4 1,250 29.60
5 450 29.69
6 1,550 29.70
7 100 29.77
8 1,100 29.80
9 750 29.82
10 500 29.85
11 100 29.86
12 200 29.87
13 150 29.89
14 100 29.95
15 3,000 30.00
12,000 29.7665
February 15, 2002
SHARES
TRADE LOT PURCHASED PRICE
--------- --------- -------
1 1,300 29.54
2 200 29.55
3 100 29.59
4 900 29.62
5 500 29.65
6 600 29.66
7 350 29.67
8 50 29.70
9 1,750 29.74
10 50 29.75
11 200 29.78
12 1,500 29.85
13 500 29.86
14 1,000 29.87
15 100 29.88
16 50 29.89
17 1,350 29.90
10,500 29.7458
Page 26 of 26